Sigma Healthcare : Becoming a substantial holder

Published: 2022-01-12 03:58:06 ET SIG.AX

Form 603

Corporations Act 2001

Section 671B

Notice of initial substantial holder

For personal use only

ToCompany Name/Scheme

Sigma Healthcare Ltd

ACN/ARSN

088 417 403

1. Details of substantial holder (1)

Name

Spheria Asset Management Pty Ltd

ACN/ARSN (if applicable)

611 081 326

The holder became a substantial holder on 10/01/2022

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class of securities (4)

Number of securities

Person's votes (5)

Voting power (6)

ORDINARY FULLY PAID

53,255,186

5.03%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holder of relevant interest

Nature of relevant interest (7)

Class and number of securities

REFER TO ANNEXURE A

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder of relevant

Registered holder of

Person entitled to be

Class and number of securities

interest

securities

registered as holder (8)

REFER TO ANNEXURE B

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Holder of relevant

Date of acquisition

Consideration (9)

Class and number of securities

interest

Cash

Non-cash

REFER TO ANNEXURE C

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name and ACN/ARSN (if applicable)

Nature of association

N/A

only

7. Addresses

The addresses of persons named in this form are as follows:

Name

Address

REFER TO ANNEXURE D

use

Signature

print name

MATTHEW BOOKER

capacity

DIRECTOR

sign here

date

12/01/2022

personal

(a) any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of

DIRECTIONS

(1)

If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the

manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of

persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each

group, with the names and addresses of members is clearly set out in paragraph 7 of the form.

(2)

See the definition of "associate" in section 9 of the Corporations Act 2001.

(3)

See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

(4)

The voting shares of a company constitute one class unless divided into separate classes.

(5)

The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an

associate has a relevant interest in.

(6)

The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.

(7)

Include details of:

For

any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any

contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or

arrangement; and

(b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or

disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification

applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

(8)

If the substantial holder is unable to determine the identity of the person ( eg. if the relevant interest arises because of an option) write

"unknown".

relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

Sigma Healthcare Ltd

Annexure A

Holder of relevant interest

Nature of relevant interest

Number of

Class of securities

securities

Spheria Asset Management Pty Ltd

Spheria Asset Management Pty Ltd in its capacity as

53,255,186

Ordinary fully paid

investment manager has the power to control voting and/or

disposal of securities.

onlyThis is Annexure "A" as mentioned in form 603 Notice of initial substantial holder

Matthew Booker

Director

Date: 12/01/2022 usepersonal

Sigma Healthcare Ltd

Annexure B

Holder of relevant interest

Registered holder of securities

Person entitled to be

Number of

Class of

registered as holder

securities

Spheria Asset Management

BNP Paribas

6,808,959

Ordinary fully paid

Spheria Asset Management

BNP Paribas Securities Services

BNP Paribas Securities

5,843,233

Ordinary fully paid

only

Services

Spheria Asset Management

Citibank

21,347,934

Ordinary fully paid

Spheria Asset Management

JP Morgan Chase Bank

6,962,361

Ordinary fully paid

Spheria Asset Management

Northern Trust

12,292,699

Ordinary fully paid

use

This is Annexure "B" as mentioned in form 603 Notice of initial substantial holder

Matthew Booker

personal

Director

Date: 12/01/2022

Sigma Healthcare Ltd

Annexure C

Holder of relevant interest

Trade Date

Consideration

Cash

Non-cash

Pinnacle Investment Management

Group Limited (and its

2021-09-17 to

subsidiaries listed in Annexure A)

2022-01-10

10,208,169.96

This is Annexure "C" as mentioned in form 603 Notice of initial substantial holder

only

Sigma Healthcare Ltd

Director

Date: 12/01/2022

use

For personal

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Sigma Healthcare Limited published this content on 12 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 January 2022 08:55:05 UTC.